XML 38 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Loan and Security Agreement - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 09, 2022
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Debt Instrument [Line Items]            
Debt instrument drew     $ 30,000,000   $ 30,000,000  
Interest rate         12.57%  
Default interest rate   5.00%        
Interest expense     1,000,000 $ 1,000,000 $ 2,900,000 $ 2,900,000
K2HV [Member]            
Debt Instrument [Line Items]            
Principal amount   $ 60,000,000        
Facility fee   $ 400,000        
Additional principal amount percentage   1.00%        
Term loan maturity date   Sep. 01, 2026        
Interest only payment term   24 months        
Interest only payment extended term 12 months 36 months        
Contractual interest rate   8.75%        
Interest rate   9.90%     9.90%  
Conversion price   $ 4.785        
Final fee   6.00%        
Covenant terms         During the term of the Loan Agreement, the Company must maintain minimum unrestricted cash and cash equivalents equal to 5.0 times the average monthly cash burn measured over the trailing three-month period.  
K2HV [Member] | Prime Rate [Member]            
Debt Instrument [Line Items]            
Prime rate   4.75%        
Tranche One [Member] | K2HV [Member]            
Debt Instrument [Line Items]            
Debt instrument drew   $ 30,000,000        
Tranche Two [Member] | K2HV [Member]            
Debt Instrument [Line Items]            
Debt instrument remaining borrowing capacity   10,000,000        
Tranche Three [Member] | K2HV [Member]            
Debt Instrument [Line Items]            
Debt instrument remaining borrowing capacity   $ 20,000,000        
Maximum [Member] | K2HV [Member]            
Debt Instrument [Line Items]            
Prepayment fee range   4.00%        
Minimum [Member] | K2HV [Member]            
Debt Instrument [Line Items]            
Prepayment fee range   1.00%        
Covenant Terms, Unrestricted Cash and Cash Equivalents     $ 5,000,000   $ 5,000,000